Clinical signs and management of anxiety, sleeplessness, and cognitive dysfunction in the senior pet

Veterinary Clinics of North America - Small Animal Practice

Volumn 41, Issue 3, 2011, Pages 565-590

  Landsberg, Gary M ^a,b   DePorter, Theresa ^c   Araujo, Joseph A ^b,d  

^a North Toronto Animal Clinic   (Canada)

^b CanCog Technologies Incorporated   (Canada)

^c Oakland Veterinary Referral Services   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anxiety; Behavior problems; Cognitive dysfunction; Fear; Night waking; Senior pets

Indexed keywords

ADRAFINIL; ALPHA CASEIN; ALPRAZOLAM; AMANTADINE; ANXITANE; BERBERINE; BUSPIRONE; CLONAZEPAM; DAP AND FELIWAY; DIAZEPAM; DIPHENHYDRAMINE; FLUOXETINE; GABAPENTIN; HARMONEASE; HONOKIOL; LAVENDER OIL; LORAZEPAM; MELATONIN; MEMANTINE; MODAFINIL; NATURAL PRODUCT; OXAZEPAM; PAROXETINE; PHENOBARBITAL; PHEROMONE; POTASSIUM BROMIDE; PROPENTOFYLLINE; SELEGILINE; SERTRALINE; SUNTHEANINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIVITONIN; ZYLKENE INTERVET;

ANXIETY; BEHAVIOR DISORDER; CAT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CLINICAL OBSERVATION; COGNITIVE DEFECT; COGNITIVE DYSFUNCTION SYNDROME; DEGENERATIVE DISEASE; DIFFERENTIAL DIAGNOSIS; DOG; GENERALIZED ANXIETY DISORDER; INSOMNIA; MENTAL DISEASE; MONITORING; MORNING DOSAGE; NOISE PHOBIA; NONHUMAN; OUTCOME ASSESSMENT; PET ANIMAL; PHOBIA; REVIEW; SENESCENCE; SEPARATION ANXIETY;

AGING; ANIMALS; ANXIETY; BEHAVIOR THERAPY; BEHAVIOR, ANIMAL; CAT DISEASES; CATS; COGNITION DISORDERS; DOG DISEASES; DOGS; HUMANS; SLEEP INITIATION AND MAINTENANCE DISORDERS; VETERINARY MEDICINE;

ANIMALIA;

EID: 79956090494     PISSN: 01955616     EISSN: 18781306     Source Type: Journal    
DOI: 10.1016/j.cvsm.2011.03.017     Document Type: Review

References (80)

1. Landsberg G.M., Hunthausen W., Ackerman L. The effects of aging on the behavior of senior pets. Handbook of behavior problems of the dog and cat 2003, Saunders, Philadelphia, p. 269-304. 2nd edition.
2. McMillan F.D. Maximizing quality of life in ill animals. J Am Anim Hosp Assoc 2003, 39(3):227-235.
3. Epstein M., Kuehn N., Landsberg G., et al. AAHA senior care guidelines for dogs and cats. J Am Anim Hosp Assoc 2005, 41(2):81-91.
4. American Association of Feline Practitioners Senior Care Guidelines Available at:, Accessed June 22, 2010. http://www.catvets.com/professionals/guidelines/publications/?Id=398.
5. Milgram N.W., Head E.A., Zicker S.C., et al. Long term treatment with antioxidants and a program of behavioral enrichment reduces age-dependant impairment in discrimination and reversal learning in beagle dogs. Exp Gerontol 2004, 39(5):753-765.
6. Barak Y., Aizenberg D. Is dementia preventable? Focus on Alzheimer's disease. Expert Rev Neurother 2010, 10(11):1689-1698.
7. Salvin H.E., McGreevy P.D., Sachev P.S., et al. Under diagnosis of canine cognitive dysfunction; a cross-sectional survey of older companion dogs. Vet J 2010, 184(3):277-281.
8. Nielson J.C., Hart B.L., Cliff K.D., et al. Prevalence of behavioral changes associated with age-related cognitive impairment in dogs. J Am Vet Med Assoc 2001, 218(11):1787-1791.
9. Golini L., Colangeli R., Tranquillo V., et al. Association between neurologic and cognitive dysfunction signs in a sample of aging dogs. J Vet Behav 2009, 4(1):25-30.
10. Osella M.C., Re G., Odore R., et al. Canine cognitive dysfunction syndrome: Prevalence, clinical signs and treatment with a neuroprotective nutraceutical. Appl Anim Behav Sci 2007, 105(4):297-310.
11. Mariotti VM, Landucci M, Lippi I, et al. Epidemiological study of behavioural disorders in elderly dogs [abstract]. In: Heath S, editor. Proceedings 7th International Meeting of Veterinary Behaviour Medicine. Belgium: ESVCE; 2009. p. 241-43.
12. Horwitz D. Dealing with common behavior problems in senior dogs. Vet Med 2001, 96(11):869-887.
13. Azkona G., Garcia-Beleguer S., Chacon G., et al. Prevalence and risk factors of behavioral changes associated with age-related cognitive impairment in geriatric dogs. J Small Anim Pract 2009, 50(2):87-91.
14. Hart B.L. Effect of gonadectomy on subsequent development of age-related cognitive impairment in dogs. J Am Vet Med Assoc 2001, 219(1):51-56.
15. Landsberg G., Denenberg S., Araujo J. Cognitive dysfunction in cats. A syndrome we used to dismiss as old age. J Feline Med Surg 2010, 12(11):837-848.
16. Gunn-Moore D., Moffat K., Christie L.A., et al. Cognitive dysfunction and the neurobiology of ageing in cats. J Small Anim Pract 2007, 48(10):546-553.
17. Johnson R.W. The concept of sickness behavior: a brief chronological account of four key discoveries. Vet Immunol Immunopathol 2002, 87(3-4):443-450.
18. Waisglass S.E., Landsberg G.M., Yager J.A., et al. Underlying medical conditions in cats with presumptive psychogenic alopecia. J Am Vet Med Assoc 2006, 228(11):1705-1709.
19. Hielm Bjorkman A.K., Kuusela E., Liman A., et al. Evaluation of methods for assessment of pain associated with chronic osteoarthritis in dogs. J Am Vet Med Assoc 2003, 222(11):1552-1558.
20. Hellyer P., Rodan I., Brunt J., et al. AAHA/AAFP Pain Management Guidelines for dogs and cats. J Feline Med Surg 2007, 9(6):466-480.
21. Lascelles D. Robertson SA DJD-associated pain in cats. What can we do to promote patient comfort?. J Feline Med Surg 2010, 12(3):200-212.
22. Bécuwe V., Bélanger M.C., Frank D., et al. Gastrointestinal disease in dogs with excessive licking of surfaces [abstract #173]. J Vet Intern Med 2009, 23:736.
23. Horwitz D. Behavioral and environmental factors associated with elimination behavior problems in cats: a retrospective study. Appl Anim Behav Sci 1997, 52(1):129-137.
24. Berteselli G.V., Servidaq F., DallAra P., et al. Evaluation of the immunological, stress and behavioral parameters in dogs (Canis familiaris) with anxiety-related disorders. Current issues and research in veterinary behavioral medicine 2005, 18-22. Purdue Press, West Lafayette (IN). D. Mills, E. Levine, G. Landsberg (Eds.).
25. Riva J., Bondiolotti G., Micelazzi M., et al. Anxiety related behavioural disorders and neurotransmitters in dogs. Appl Anim Behav Sci 2008, 114(1):168-181.
26. Dreschel N.A. Anxiety, fear, disease and lifespan in domestic dogs. J Vet Behav 2009, 4(6):249-250.
27. Weistropp J.L., Kass P.H., Buffington C.A.T. Evaluation of the effects of stress in cats with Idiopathic cystitis. Am J Vet Res 2006, 67(4):731-736.
28. Buffington C.A.T., Pacak K. Increased plasma norepinephrine concentration in cats with interstitial cystitis. J Urol 2001, 165(6 part 1):2051-2054.
29. Buffington C.A.T., Westropp J.L., Chew D.J., et al. Clinical evaluation of multimodal environmental modification (MEMO) in the management of cats with idiopathic cystitis. J Feline Med Surg 2006, 8(4):261-268.
30. Virga V. Behavioral dermatology. Vet Clin North Am 2003, 33(2):231-251.
31. Nagata M., Shibata K. Importance of psychogenic factors in canine recurrent pyoderma. Vet Dermatol 2004, 15(s1):42.
32. Nagata M., Shibata K., Irimajiri M., et al. Importance of psychogenic dermatoses in dogs with pruritic behavior. Vet Dermatol 2002, 13(4):211-219.
33. Overall K.L. Dogs as " natural" models of human psychiatric disorders: assessing validity and understanding mechanism. Prog Neuropsychopharmacol Biol Psychiatry 2000, 24(5):727-776.
34. Borras D., Ferrer I., Pumarola M. Age related changes in the brain of the dog. Vet Pathol 1999, 36(3):202-211.
35. Tapp P.D., Siwak C.T., Gao F.Q., et al. Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging. J Neurosci 2004, 24(38):8205-8213.
36. Zhang C., Hua T., Zhu Z., et al. Age related changes of structures in cerebellar cortex of cat. J Biosci 2006, 31(1):55-60.
37. Cummings B.J., Satou T., Head E., et al. Diffuse plaques contain c-terminal AB42 and not AB40: evidence from cats and dogs. Neurobiol Aging 1996, 17(4):653-659.
38. Cummings B.J., Head E., Afagh A.J., et al. B-Amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem 1996, 66(1):11-23.
39. Colle M.A., Hauw J.J., Crespau F., et al. Vascular and parenchymal beta-amyloid deposition in the aging dog: correlation with behavior. Neurobiol Aging 2000, 21(5):695-704.
40. Nakamura S., Nakayama H., Kiatipattanasakul W., et al. Senile plaques in very aged cats. Acta Neuropathol 1996, 91(4):437-439.
41. Head E., Liu J., Hagen T.M., et al. Oxidative damage increases with age in a canine model of human brain aging. J Neurochem 2002, 82(2):375-381.
42. Araujo J.A., Studzinski C.M., Milgram N.W., et al. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29(3):411-422.
43. Araujo J.A., Chan A.D., Winka L.L., et al. Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination. Psychopharmacology 2004, 175(1):92-98.
44. Pugliese M., Cangitano C., Ceccariglia S., et al. Canine cognitive dysfunction and the cerebellum: acetylcholinesterase reduction, neuronal and glial changes. Brain Res 2007, 1139:85-94.
45. Zhang J.H., Sampogna S., Morales F.R., et al. Age-related changes in cholinergic neurons in the laterodorsal and the pedunculo-pontine tegmental nuclei of cats: a combined light and electron microscopic study. Brain Res 2005, 1052:47-55.
46. Head E., McCleary R., Hahn F.F., et al. Region-specific age at onset of beta-amyloid in dogs. Neurobiol Aging 2000, 21(1):89-96.
47. Gunn-Moore D.A., McVee J., Bradshaw J.M., et al. β-Amyloid and hyper-phosphorylated tau deposition in cat brains. J Feline Med Surg 2006, 8(4):234-242.
48. Head E., Moffat K., Das P., et al. Beta-amyloid deposition and tau phosphorylation in clinically characterized aged cats. Neurobiol Aging 2005, 26(5):749-763.
49. Shepherd K. Behavioural medicine as an integral part of veterinary practice. BSAVA Manual of Canine and Feline Behavioural Medicine 2010, 10-23. British Small Animal Veterinary Association, Gloucester (UK). 2nd edition. D. Horwitz, D. Mills, S. Heath (Eds.).
50. Tapp P.D., Siwak C.T., Estrada J., et al. Size and reversal learning in the beagle dog as a measure of executive function and inhibitory control in aging. Learn Mem 2003, 10(1):64-73.
51. Studzinski C.M., Christie L.-A., Araujo J.A., et al. Visuospatial function in the beagle dog: an early marker of cognitive decline in a model of human cognitive aging and dementia. Neurobiol Learn Mem 2006, 86(2):197-204.
52. Milgram N.W., Head E., Weiner E., et al. Cognitive functions and aging in the dog: acquisition of nonspatial visual tasks. Behav Neurosci 1994, 108(1):57-68.
53. Milgram NW. Neuropsychological function and aging in cats. Proceedings of Canine Cognition and Aging 15th Annual Conference. Laguna Beach, November 11, 12, 2010.
54. Siwak C.T., Tapp P.D., Milgram N.W. Effect of age and level of cognitive function on spontaneous and exploratory behaviors in the beagle dog. Learn Mem 2001, 8(6):65-70.
55. Harrison J., Buchwald J. Eyeblink conditioning deficits in the old cat. Neurobiol Aging 1983, 4(1):45-51.
56. Levine M.S., Lloyd R.L., Fisher R.S., et al. Sensory, motor and cognitive alterations in aged cats. Neurobiol Aging 1987, 8(3):253-263.
57. Levine M.S., Lloyd R.L., Hull C.D., et al. Neurophysiological alterations in caudate neurons in aged cats. Brain Res 1987, 401(2):213-230.
58. Senanarong V., Cummings J.L., Fairbanks L., et al. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction. Dement Geriatr Cogn Disord 2004, 17(1-2):14-20.
59. McCurry S.M., Gibbons L.E., Logsdon R.G., et al. Anxiety and nighttime behavioral disturbances. Awakenings in patients with Alzheimer's disease. J Gerontol Nurs 2004, 30(1):12-20.
60. Salvin H.E., McGreevy P.D., Sachdev P.S., et al. The canine cognition dysfunction rating scale (CCDR): A data driven and ecologically relevant assessment tool. Vet J 2010, 10.1016/j.tvjl.2010.05.014.
61. Wells D.L. Aromatherapy for travel-induced excitement in dogs. J Am Vet Med Assoc 2006, 229(6):964-967.
62. Milgram N.W., Ivy G.O., Head E., et al. The effect of l-deprenyl on behavior, cognitive function, and biogenic amines in the dog. Neurochem Res 1993, 18(12):1211-1219.
63. Carillo M.C., Ivy G.O., Milgram N.W., et al. Deprenyl increases activity of superoxide dismutase in striatum of dog brain. Life Sci 1994, 54:1483-1489.
64. Landsberg G. Therapeutic options for cognitive decline in senior pets. J Am Anim Hosp Assoc 2006, 42(6):407-413.
65. Siwak C.T., Gruet P., Woehrle F., et al. Behavioral activating effects of adrafinil in aged canines. Pharmacol Biochem Behav 2000, 66(2):293-300.
66. Siwak C.T., Gruet P., Woehrle F., et al. Comparison of the effects of adrafinil, propentofylline and nicergoline on behavior in aged dogs. Am J Vet Res 2000, 61(11):1410-1414.
67. Martinez-Coria H., Green K.N., Billings L.M., et al. Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice. Am J Pathol 2010, 176(2):870-880.
68. Studzinski C.M., Araujo J.A., Milgram N.W. The canine model of human cognitive aging and dementia: Pharmacological validity of the model for assessment of human cognitive-enhancing drugs. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29(3):489-498.
69. Joseph J.A., Shukitt-Hale B., Denisova N.A., et al. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal transduction and cognitive behavioral deficits. J Neurosci 1998, 18(19):8047-8055.
70. Barberger-Gateau P., Raffaitin C., Letenneur L., et al. Dietary Patterns and Risk of Dementia: a three-city cohort study. Neurology 2007, 69(20):1921-1930.
71. Milgram N.W., Zicker S.C., Head E., et al. Dietary enrichment counteracts age-associated cognitive dysfunction in canines. Neurobiol Aging 2002, 23(5):737-745.
72. Araujo J.A., Studzinski C.M., Head E., et al. Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging. Age 2005, 27(1):27-37.
73. Pan Y., Larson B., Araujo J.A., et al. Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs. Br J Nutr 2010, 103(12):1746-1754.
74. Taha A.Y., Henderson S.T., Burnham W.M. Dietary enrichment with medium chain-triglycerides (AC-1203) elevates polyunsaturated fatty acids in the parietal cortex of aged dogs; implications for treating age-related cognitive decline. Neurochem Res 2009, 34(9):1619-1625.
75. Studzinski C.M., MacKay W.A., Beckett T.L., et al. Induction of ketosis may improve mitochondrial function and decrease steady-state amyloid-beta precursor protein (APP) levels in the aged dog. Brain Res 2008, 1226:209-217.
76. Cena F., Colangeli R., Fassola F., et al. Effect of a combination of phosphatidylserine, Gingko biloba, vitamin E and pyridoxine on clinical signs of brain ageing; a pilot multicentric study. Behaviour and internal medicine 2005, 127-135. ESVCE, Marseille. C. Beata, S. Heath, P. Pageat (Eds.).
77. Heath S.E., Barabas S., Craze P.G. Nutritional supplementation in cases of canine cognitive dysfunction - a clinical trial. Appl Anim Behav Sci 2007, 105(4):274-283.
78. Araujo J.A., Landsberg G.M., Milgram N.W., et al. Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E and pyridoxine. Can Vet J 2008, 49(4):379-385.
79. Bottiglieri T. S-Adenosyl-l-methionine (SAMe): from the bench to the bedside-molecular basis of a pleiotrophic molecule. Am J Clin Nutr 2002, 76(suppl):1151S-1157S.
80. Rème C.A., Dramard V., Kern L., et al. Effect of S-adenosylmethionine tablets on the reduction of age-related mental decline in dogs: a double-blind placebo-controlled trial. Vet Ther 2008, 9(2):69-82.